Your browser doesn't support javascript.
loading
Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial.
Umemura, Yoshie; Orringer, Daniel; Junck, Larry; Varela, Maria L; West, Molly E J; Faisal, Syed M; Comba, Andrea; Heth, Jason; Sagher, Oren; Leung, Denise; Mammoser, Aaron; Hervey-Jumper, Shawn; Zamler, Daniel; Yadav, Viveka N; Dunn, Patrick; Al-Holou, Wajd; Hollon, Todd; Kim, Michelle M; Wahl, Daniel R; Camelo-Piragua, Sandra; Lieberman, Andrew P; Venneti, Sriram; McKeever, Paul; Lawrence, Theodore; Kurokawa, Ryo; Sagher, Karen; Altshuler, David; Zhao, Lili; Muraszko, Karin; Castro, Maria G; Lowenstein, Pedro R.
Affiliation
  • Umemura Y; Department of Neurology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Orringer D; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Junck L; Department of Neurology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Varela ML; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA; Department of Cell and Developmental Biology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA; The Rogel Cancer Center, The University of Michigan
  • West MEJ; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA; Department of Cell and Developmental Biology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA; The Rogel Cancer Center, The University of Michigan
  • Faisal SM; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA; Department of Cell and Developmental Biology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA; The Rogel Cancer Center, The University of Michigan
  • Comba A; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA; Department of Cell and Developmental Biology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA; The Rogel Cancer Center, The University of Michigan
  • Heth J; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Sagher O; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Leung D; Department of Neurology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Mammoser A; Department of Neurology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Hervey-Jumper S; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Zamler D; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Yadav VN; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Dunn P; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Al-Holou W; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Hollon T; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Kim MM; Department of Radiation Oncology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Wahl DR; Department of Radiation Oncology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Camelo-Piragua S; Department of Pathology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Lieberman AP; Department of Pathology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Venneti S; Department of Pathology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • McKeever P; Department of Pathology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Lawrence T; Department of Radiation Oncology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Kurokawa R; Department of Radiology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Sagher K; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Altshuler D; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Zhao L; Department of Biostatistics, The University of Michigan School of Public Health, University of Michigan, Ann Arbor, MI, USA.
  • Muraszko K; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA.
  • Castro MG; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA; Department of Cell and Developmental Biology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA; The Rogel Cancer Center, The University of Michigan
  • Lowenstein PR; Department of Neurosurgery, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA; Department of Cell and Developmental Biology, The University of Michigan Medical School, University of Michigan, Ann Arbor, MI, USA; The Rogel Cancer Center, The University of Michigan
Lancet Oncol ; 24(9): 1042-1052, 2023 09.
Article de En | MEDLINE | ID: mdl-37657463

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Glioblastome / Gliome / Antinéoplasiques Type d'étude: Prognostic_studies Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Lancet Oncol Sujet du journal: NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Glioblastome / Gliome / Antinéoplasiques Type d'étude: Prognostic_studies Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Lancet Oncol Sujet du journal: NEOPLASIAS Année: 2023 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni